• Reduces levels of total cholesterol, LDL- Cholesterol, toggle cedes and VLDL-Cholesterol, and increases HDL-Cholesterol.
• In CHD patients, exhibits more efficacious results than lovastatin, provastatin, Fluvastatin and simvastatin in actively target LDL-cholestrol.
• More cost effective than other most HMG-COA reduetare inhibition in achieving target LDL cholesterol levels.
• Well tolerated with moderate and transient adverse events.